Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano; H. J. Burstein; E. P. Winer; M. Gnant; P. Dubsky; S. Loibl; M. Colleoni; M. M. Regan; M. Piccart-Gebhart; H. J. Senn; B. Thürlimann; F. André; J. Baselga; J. Bergh; H. Bonnefoi; S. Y. Brucker; F. Cardoso; L. Carey; E. Ciruelos; J. Cuzick; C. Denkert; A. Di Leo; B. Ejlertsen; P. Francis; V. Galimberti; J. Garber; B. Gulluoglu; P. Goodwin; N. Harbeck; D. F. Hayes; C. S. Huang; J. Huober; H. Khaled; J. Jassem; Z. Jiang; P. Karlsson; M. Morrow; R. Orecchia; K. C. Osborne; O. Pagani; A. H. Partridge; K. Pritchard; J. Ro; E. J.T. Rutgers; F. Sedlmayer; V. Semiglazov; Z. Shao; I. Smith; M. Toi; A. Tutt; G. Viale; T. Watanabe; T. J. Whelan; B. Xu

doi:10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano, H. J. Burstein, E. P. Winer, M. Gnant, P. Dubsky, S. Loibl, M. Colleoni, M. M. Regan, M. Piccart-Gebhart, H. J. Senn, B. Thürlimann, F. André, J. Baselga, J. Bergh, H. Bonnefoi, S. Y. Brucker, F. Cardoso, L. Carey, E. Ciruelos, J. CuzickC. Denkert, A. Di Leo, B. Ejlertsen, P. Francis, V. Galimberti, J. Garber, B. Gulluoglu, P. Goodwin, N. Harbeck, D. F. Hayes, C. S. Huang, J. Huober, H. Khaled, J. Jassem, Z. Jiang, P. Karlsson, M. Morrow, R. Orecchia, K. C. Osborne, O. Pagani, A. H. Partridge, K. Pritchard, J. Ro, E. J.T. Rutgers, F. Sedlmayer, V. Semiglazov, Z. Shao, I. Smith, M. Toi, A. Tutt, G. Viale, T. Watanabe, T. J. Whelan, B. Xu

Résultats de recherche: Contribution à un journal › !!Comment/debate

62 Citations (Scopus)

Résumé

In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

langue originale	Anglais
Numéro d'article	mdy537
Pages (de - à)	1181
Nombre de pages	1
journal	Annals of Oncology
Volume	30
Numéro de publication	7
Les DOIs	https://doi.org/10.1093/annonc/mdy537
état	Publié - 1 juil. 2019

Accès au document

10.1093/annonc/mdy537

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H. J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., ... Xu, B. (2019). Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology, 30(7), 1181. Article mdy537. https://doi.org/10.1093/annonc/mdy537

Curigliano, G. ; Burstein, H. J. ; Winer, E. P. et al. / Corrigendum : De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Dans: Annals of Oncology. 2019 ; Vol 30, Numéro 7. p. 1181.

@article{cd9f2db3d3e647bfb3aec0b6a067e228,

title = "Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)",

abstract = "In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.",

author = "G. Curigliano and Burstein, {H. J.} and Winer, {E. P.} and M. Gnant and P. Dubsky and S. Loibl and M. Colleoni and Regan, {M. M.} and M. Piccart-Gebhart and Senn, {H. J.} and B. Th{\"u}rlimann and F. Andr{\'e} and J. Baselga and J. Bergh and H. Bonnefoi and Brucker, {S. Y.} and F. Cardoso and L. Carey and E. Ciruelos and J. Cuzick and C. Denkert and {Di Leo}, A. and B. Ejlertsen and P. Francis and V. Galimberti and J. Garber and B. Gulluoglu and P. Goodwin and N. Harbeck and Hayes, {D. F.} and Huang, {C. S.} and J. Huober and H. Khaled and J. Jassem and Z. Jiang and P. Karlsson and M. Morrow and R. Orecchia and Osborne, {K. C.} and O. Pagani and Partridge, {A. H.} and K. Pritchard and J. Ro and Rutgers, {E. J.T.} and F. Sedlmayer and V. Semiglazov and Z. Shao and I. Smith and M. Toi and A. Tutt and G. Viale and T. Watanabe and Whelan, {T. J.} and B. Xu",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = jul,

day = "1",

doi = "10.1093/annonc/mdy537",

language = "English",

volume = "30",

pages = "1181",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "7",

}

Curigliano, G, Burstein, HJ, Winer, EP, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, MM, Piccart-Gebhart, M, Senn, HJ, Thürlimann, B, André, F, Baselga, J, Bergh, J, Bonnefoi, H, Brucker, SY, Cardoso, F, Carey, L, Ciruelos, E, Cuzick, J, Denkert, C, Di Leo, A, Ejlertsen, B, Francis, P, Galimberti, V, Garber, J, Gulluoglu, B, Goodwin, P, Harbeck, N, Hayes, DF, Huang, CS, Huober, J, Khaled, H, Jassem, J, Jiang, Z, Karlsson, P, Morrow, M, Orecchia, R, Osborne, KC, Pagani, O, Partridge, AH, Pritchard, K, Ro, J, Rutgers, EJT, Sedlmayer, F, Semiglazov, V, Shao, Z, Smith, I, Toi, M, Tutt, A, Viale, G, Watanabe, T, Whelan, TJ & Xu, B 2019, 'Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)', Annals of Oncology, VOL. 30, Numéro 7, mdy537, p. 1181. https://doi.org/10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). / Curigliano, G.; Burstein, H. J.; Winer, E. P. et al.
Dans: Annals of Oncology, Vol 30, Numéro 7, mdy537, 01.07.2019, p. 1181.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

AU - Curigliano, G.

AU - Burstein, H. J.

AU - Winer, E. P.

AU - Gnant, M.

AU - Dubsky, P.

AU - Loibl, S.

AU - Colleoni, M.

AU - Regan, M. M.

AU - Piccart-Gebhart, M.

AU - Senn, H. J.

AU - Thürlimann, B.

AU - André, F.

AU - Baselga, J.

AU - Bergh, J.

AU - Bonnefoi, H.

AU - Brucker, S. Y.

AU - Cardoso, F.

AU - Carey, L.

AU - Ciruelos, E.

AU - Cuzick, J.

AU - Denkert, C.

AU - Di Leo, A.

AU - Ejlertsen, B.

AU - Francis, P.

AU - Galimberti, V.

AU - Garber, J.

AU - Gulluoglu, B.

AU - Goodwin, P.

AU - Harbeck, N.

AU - Hayes, D. F.

AU - Huang, C. S.

AU - Huober, J.

AU - Khaled, H.

AU - Jassem, J.

AU - Jiang, Z.

AU - Karlsson, P.

AU - Morrow, M.

AU - Orecchia, R.

AU - Osborne, K. C.

AU - Pagani, O.

AU - Partridge, A. H.

AU - Pritchard, K.

AU - Ro, J.

AU - Rutgers, E. J.T.

AU - Sedlmayer, F.

AU - Semiglazov, V.

AU - Shao, Z.

AU - Smith, I.

AU - Toi, M.

AU - Tutt, A.

AU - Viale, G.

AU - Watanabe, T.

AU - Whelan, T. J.

AU - Xu, B.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

AB - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

UR - http://www.scopus.com/inward/record.url?scp=85071164178&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy537

DO - 10.1093/annonc/mdy537

M3 - Comment/debate

C2 - 30624592

AN - SCOPUS:85071164178

SN - 0923-7534

VL - 30

SP - 1181

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

M1 - mdy537

ER -

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S et al. Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology. 2019 juil. 1;30(7):1181. mdy537. doi: 10.1093/annonc/mdy537